PURA VIDA INVESTMENTS, LLC - Q4 2016 holdings

$273 Million is the total value of PURA VIDA INVESTMENTS, LLC's 70 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 74.3% .

 Value Shares↓ Weighting
AGN SellALLERGAN PLCput$8,400,000
-14.2%
40,000
-5.9%
3.08%
+3.6%
NXTM SellNXSTAGE MEDICAL INC$6,749,000
-26.0%
257,500
-29.5%
2.47%
-10.7%
BAX SellBAXTER INTL INC$6,651,000
-12.7%
150,000
-6.2%
2.44%
+5.4%
KTWO SellK2M GROUP HLDGS INC$4,854,000
-27.2%
242,200
-35.5%
1.78%
-12.1%
AET SellAETNA INC NEW$4,836,000
-39.6%
39,000
-43.7%
1.77%
-27.1%
SIEN SellSIENTRA INC$4,260,000
-14.3%
500,000
-9.5%
1.56%
+3.5%
MEDP SellMEDPACE HLDGS INC$3,697,000
-21.9%
102,507
-35.3%
1.36%
-5.7%
FXH SellFIRST TR EXHANGE TRADED FDput$3,438,000
-62.3%
60,000
-60.0%
1.26%
-54.5%
WMGI SellWRIGHT MED GROUP N V$3,217,000
-15.4%
140,000
-9.7%
1.18%
+2.1%
IVC SellINVACARE CORP$2,916,000
-15.8%
223,439
-27.9%
1.07%
+1.6%
AVXS SellAVEXIS INC$2,500,000
-45.3%
52,375
-52.8%
0.92%
-34.0%
AGN SellALLERGAN PLC$1,407,000
-43.2%
6,700
-37.7%
0.52%
-31.4%
ARAY SellACCURAY INC$1,374,000
-56.9%
298,793
-40.2%
0.50%
-47.9%
VIVE SellVIVEVE MED INC$808,000
-64.3%
156,899
-49.9%
0.30%
-56.9%
AMRN SellAMARIN CORP PLCspons adr new$770,000
-49.2%
250,000
-47.4%
0.28%
-38.7%
FPRX SellFIVE PRIME THERAPEUTICS INC$709,000
-9.9%
14,150
-5.7%
0.26%
+8.8%
NXTM SellNXSTAGE MEDICAL INCcall$278,000
-88.5%
10,600
-89.1%
0.10%
-86.2%
HSGX SellHISTOGENICS CORP$23,000
-83.8%
13,526
-69.4%
0.01%
-81.4%
ExitNEOVASC INC$0-588,594
-100.0%
-0.09%
TTOO ExitT2 BIOSYSTEMS INC$0-60,929
-100.0%
-0.13%
ARAY ExitACCURAY INCcall$0-100,000
-100.0%
-0.19%
AVGR ExitAVINGER INCcall$0-150,000
-100.0%
-0.22%
ADMP ExitADAMIS PHARMACEUTICALS CORP$0-255,000
-100.0%
-0.27%
HZNP ExitHORIZON PHARMA PLCcall$0-50,000
-100.0%
-0.28%
ITEK ExitINOTEK PHARMACEUTICALS CORP$0-111,468
-100.0%
-0.32%
RDUS ExitRADIUS HEALTH INC$0-19,775
-100.0%
-0.32%
FLKS ExitFLEX PHARMA INC$0-142,000
-100.0%
-0.51%
OPHT ExitOPHTHOTECH CORPcall$0-37,200
-100.0%
-0.52%
EXAS ExitEXACT SCIENCES CORPcall$0-100,000
-100.0%
-0.56%
OPHT ExitOPHTHOTECH CORP$0-42,500
-100.0%
-0.60%
KITE ExitKITE PHARMA INCput$0-39,500
-100.0%
-0.67%
SGYPQ ExitSYNERGY PHARMACEUTICALS DEL$0-412,500
-100.0%
-0.69%
THC ExitTENET HEALTHCARE CORP$0-105,000
-100.0%
-0.72%
SRPT ExitSAREPTA THERAPEUTICS INC$0-40,000
-100.0%
-0.75%
SPNC ExitSPECTRANETICS CORP$0-100,000
-100.0%
-0.76%
AVGR ExitAVINGER INC$0-571,298
-100.0%
-0.83%
HZNP ExitHORIZON PHARMA PLC$0-151,250
-100.0%
-0.83%
KITE ExitKITE PHARMA INC$0-49,500
-100.0%
-0.84%
RARE ExitULTRAGENYX PHARMACEUTICAL IN$0-39,750
-100.0%
-0.86%
OFIX ExitORTHOFIX INTL N V$0-70,000
-100.0%
-0.91%
PODD ExitINSULET CORP$0-74,600
-100.0%
-0.93%
HRC ExitHILL ROM HLDGS INC$0-50,000
-100.0%
-0.94%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-49,125
-100.0%
-1.00%
THC ExitTENET HEALTHCARE CORPcall$0-150,000
-100.0%
-1.03%
ZLTQ ExitZELTIQ AESTHETICS INC$0-90,000
-100.0%
-1.07%
AKRXQ ExitAKORN INC$0-135,125
-100.0%
-1.12%
ABT ExitABBOTT LABScall$0-87,700
-100.0%
-1.13%
ALR ExitALERE INC$0-90,000
-100.0%
-1.18%
ACAD ExitACADIA PHARMACEUTICALS INC$0-123,066
-100.0%
-1.19%
MOH ExitMOLINA HEALTHCARE INC$0-70,000
-100.0%
-1.24%
JAZZ ExitJAZZ PHARMACEUTICALS PLC$0-33,936
-100.0%
-1.25%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-61,625
-100.0%
-1.27%
XENT ExitINTERSECT ENT INC$0-275,000
-100.0%
-1.32%
THC ExitTENET HEALTHCARE CORPput$0-200,000
-100.0%
-1.38%
ZBH ExitZIMMER BIOMET HLDGS INC$0-40,652
-100.0%
-1.60%
GSK ExitGLAXOSMITHKLINE PLCsponsored adr$0-150,357
-100.0%
-1.97%
LLY ExitLILLY ELI & COcall$0-81,500
-100.0%
-1.99%
EVHC ExitENVISION HEALTHCARE HLDGS INput$0-300,000
-100.0%
-2.03%
EVHC ExitENVISION HEALTHCARE HLDGS IN$0-307,046
-100.0%
-2.08%
CNC ExitCENTENE CORP DEL$0-106,479
-100.0%
-2.16%
SHPG ExitSHIRE PLCsponsored adr$0-37,391
-100.0%
-2.20%
AMGN ExitAMGEN INC$0-43,460
-100.0%
-2.20%
NVS ExitNOVARTIS A Gsponsored adr$0-92,125
-100.0%
-2.21%
LLY ExitLILLY ELI & CO$0-93,375
-100.0%
-2.28%
BCR ExitBARD C R INCput$0-35,000
-100.0%
-2.38%
ALXN ExitALEXION PHARMACEUTICALS INC$0-66,375
-100.0%
-2.47%
ABT ExitABBOTT LABS$0-205,000
-100.0%
-2.63%
SYK ExitSTRYKER CORPcall$0-75,000
-100.0%
-2.65%
SYK ExitSTRYKER CORP$0-84,333
-100.0%
-2.98%
HCA ExitHCA HOLDINGS INCput$0-140,000
-100.0%
-3.22%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13

View PURA VIDA INVESTMENTS, LLC's complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings